Inhibrx Biosciences, Inc. (INBX) — Working Capital to Net Assets Ratio
Inhibrx Biosciences, Inc. (INBX) has a Working Capital to Net Assets ratio of 1239.0% as of December 2025. Working capital of $99.03 Million (current assets of $132.83 Million minus current liabilities of $33.80 Million) is measured against net assets of $7.99 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See INBX equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Inhibrx Biosciences, Inc. Working Capital to Net Assets (2016–2025)
This chart shows how Inhibrx Biosciences, Inc.'s Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the ratio stands at 1239.0%, reflecting working capital of $99.03 Million against net assets of $7.99 Million USD. Check Inhibrx Biosciences, Inc. (INBX) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Inhibrx Biosciences, Inc. (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Inhibrx Biosciences, Inc. from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Inhibrx Biosciences, Inc..
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 1239.0% | $99.03 Million | $7.99 Million | $132.83 Million | $33.80 Million | ▲ +1149.4 pp |
| 2024 | 89.6% | $119.67 Million | $133.58 Million | $160.40 Million | $40.73 Million | ▼ -459.9 pp |
| 2023 | 549.5% | $239.05 Million | $43.50 Million | $295.36 Million | $56.31 Million | ▲ +113.9 pp |
| 2022 | 435.6% | $252.92 Million | $58.06 Million | $280.49 Million | $27.58 Million | ▲ +212.9 pp |
| 2021 | 222.7% | $116.66 Million | $52.38 Million | $139.11 Million | $22.45 Million | ▲ +89.2 pp |
| 2020 | 133.5% | $100.77 Million | $75.47 Million | $132.17 Million | $31.40 Million | ▲ +128.2 pp |
| 2019 | 5.4% | $-5.01 Million | $-93.57 Million | $15.56 Million | $20.57 Million | ▼ -12.9 pp |
| 2018 | 18.3% | $-10.53 Million | $-57.64 Million | $5.66 Million | $16.18 Million | ▲ +47.3 pp |
| 2017 | -29.1% | $6.52 Million | $-22.42 Million | $15.44 Million | $8.92 Million | ▼ -1250.1 pp |
| 2016 | 1221.0% | $15.13 Million | $1.24 Million | $20.41 Million | $5.28 Million | — |